Company / Working Capital
AYTU BIOPHARMA, INC Working Capital History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$16.1M
FY2025
5-year range
-$4.5M / $16.1M
FY2021-FY2025
Trend
+4881.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital changed +4882% YoY in FY2025, a notable deviation from the 9-year average annual change of +308%.
Based on SEC 10-K filings.
$16M in FY2025 with a 10-year CAGR of +9.4%.
Improved from $4M to $16M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -19.2%
- 10-Year CAGR
- +9.4%
Key checks
Key Insights
- 5-year CAGR of -19.2%, indicating a declining trend.
- In FY2025, working capital increased 4881.9% year-over-year.
- Peak working capital was recorded in FY2020.
- Lowest working capital in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.1M | +4881.9% |
| FY2024 | -$337.0K | -108.8% |
| FY2023 | $3.8M | +184.6% |
| FY2022 | -$4.5M | -7.4% |
| FY2021 | -$4.2M | -109.0% |
| FY2020 | $46.7M | +668.0% |
| FY2018 | $6.1M | +1144.1% |
| FY2017 | -$581.9K | -3782.5% |
| FY2016 | $15.8K | -99.8% |
| FY2015 | $6.6M | +5632.3% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026